DK0533210T3 - Protein C-holdige farmaceutiske præparater som midler mod inflammation. - Google Patents

Protein C-holdige farmaceutiske præparater som midler mod inflammation.

Info

Publication number
DK0533210T3
DK0533210T3 DK92117249.0T DK92117249T DK0533210T3 DK 0533210 T3 DK0533210 T3 DK 0533210T3 DK 92117249 T DK92117249 T DK 92117249T DK 0533210 T3 DK0533210 T3 DK 0533210T3
Authority
DK
Denmark
Prior art keywords
protein
inflammation
agents
pharmaceutical preparations
containing pharmaceutical
Prior art date
Application number
DK92117249.0T
Other languages
English (en)
Inventor
Johann Eibl
Ludwig Pichler
Hans-Peter Schwarz
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Application granted granted Critical
Publication of DK0533210T3 publication Critical patent/DK0533210T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK92117249.0T 1990-08-16 1991-01-28 Protein C-holdige farmaceutiske præparater som midler mod inflammation. DK0533210T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0169790A AT402260B (de) 1990-08-16 1990-08-16 Protein c-hältige pharmazeutische präparation
EP91890012A EP0471660B1 (de) 1990-08-16 1991-01-28 Protein C zur Schmerzbekämpfung

Publications (1)

Publication Number Publication Date
DK0533210T3 true DK0533210T3 (da) 1997-11-03

Family

ID=3519039

Family Applications (3)

Application Number Title Priority Date Filing Date
DK92117248.2T DK0533209T3 (da) 1990-08-16 1991-01-28 Farmaceutisk præparat indeholdende protein C som beta-sympatomimetikum.
DK91890012.7T DK0471660T3 (da) 1990-08-16 1991-01-28 Protein C til behandling af smerte
DK92117249.0T DK0533210T3 (da) 1990-08-16 1991-01-28 Protein C-holdige farmaceutiske præparater som midler mod inflammation.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK92117248.2T DK0533209T3 (da) 1990-08-16 1991-01-28 Farmaceutisk præparat indeholdende protein C som beta-sympatomimetikum.
DK91890012.7T DK0471660T3 (da) 1990-08-16 1991-01-28 Protein C til behandling af smerte

Country Status (12)

Country Link
EP (3) EP0471660B1 (da)
JP (1) JP2530770B2 (da)
AT (6) AT402260B (da)
CA (1) CA2041380C (da)
CZ (1) CZ280004B6 (da)
DE (3) DE59106292D1 (da)
DK (3) DK0533209T3 (da)
ES (3) ES2103861T3 (da)
HR (1) HRP921237A2 (da)
HU (1) HUT60147A (da)
RU (1) RU2066550C1 (da)
YU (1) YU77591A (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571786A (en) * 1990-08-16 1996-11-05 Immuno Aktiengesellschaft Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation
AT397615B (de) * 1991-05-14 1994-05-25 Immuno Ag Arzneimittel enthaltend protein c
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DK0733371T3 (da) * 1995-03-21 2002-10-07 Baxter Ag Middel til subkutan administrering af protein C
DE19608218A1 (de) * 1995-03-21 1996-09-26 Immuno Ag Mittel zur subkutanen Verabreichung von Protein C
EP1841442A4 (en) * 2005-01-07 2009-12-09 Northern Sydney And Central Co TREATMENT OF AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES
AU2013286812B2 (en) * 2012-07-04 2017-04-20 Zz Biotech Llc Treatment of inflammatory skin disorders
PT3137102T (pt) 2014-04-16 2021-09-28 Zz Biotech Llc Apc para utilização no tratamento de cicatrização cutânea anormal
PL3131572T3 (pl) 2014-04-16 2022-02-07 Zz Biotech Llc Analog apc do zastosowania w zaleczaniu rany

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2739050B2 (ja) * 1988-01-28 1998-04-08 ヘキスト薬品工業株式会社 抗血液凝固剤
US5093117A (en) * 1989-01-24 1992-03-03 Baxter International Inc. Compositions and method for the treatment or prophylaxis of sepsis or septic shock

Also Published As

Publication number Publication date
ATE126699T1 (de) 1995-09-15
CA2041380A1 (en) 1992-02-17
EP0533210B1 (de) 1997-05-02
ATE150649T1 (de) 1997-04-15
ES2080289T3 (es) 1996-02-01
AT403763B (de) 1998-05-25
ATA169790A (de) 1996-08-15
EP0471660B1 (de) 1995-08-23
ES2103861T3 (es) 1997-10-01
YU77591A (sh) 1995-10-24
RU2066550C1 (ru) 1996-09-20
DE59106292D1 (de) 1995-09-28
ATA20492A (de) 1997-10-15
ATE152354T1 (de) 1997-05-15
CS121391A3 (en) 1992-02-19
ES2102435T3 (es) 1997-08-01
EP0471660A2 (de) 1992-02-19
JPH04230633A (ja) 1992-08-19
EP0533209B1 (de) 1997-03-26
DE59108697D1 (de) 1997-06-05
AT403439B (de) 1998-02-25
CZ280004B6 (cs) 1995-09-13
ATA20392A (de) 1997-07-15
AT402260B (de) 1997-03-25
HU911348D0 (en) 1991-10-28
JP2530770B2 (ja) 1996-09-04
EP0533209A1 (de) 1993-03-24
DE59108638D1 (de) 1997-04-30
HUT60147A (en) 1992-08-28
DK0533209T3 (da) 1997-09-22
DK0471660T3 (da) 1995-12-18
EP0471660A3 (en) 1992-04-15
CA2041380C (en) 1997-10-07
HRP921237A2 (en) 1995-10-31
EP0533210A1 (de) 1993-03-24

Similar Documents

Publication Publication Date Title
NO169493C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive peptid-derivater
IT1221826B (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
DK0533210T3 (da) Protein C-holdige farmaceutiske præparater som midler mod inflammation.
ES2054098T3 (es) Uso de minoxidilo para la curacion de heridas.
ES2063186T3 (es) Derivados ftalinida, composicion farmaceutica y uso.
FI895046A7 (fi) 4-amino-3-asyylikinoliinijohdannaiset ja niiden käyttö mahanesteiden e rittymisen estäjinä
IT1251838B (it) Uso della nimesulide nel trattamento della cataratta
DE3875349D1 (de) Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie.
ES2136799T3 (es) Benzotiofenos de glucopiranosido.
DK211489A (da) Farmaceutisk praeparat
ES2086195T3 (es) Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
FI934468A0 (fi) Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytesmellanprodukter
ES2011230A4 (es) Derivados peptidos del 3 - aminodihidrotiofeno - 2 - uno, procesos para la preparacion y uso terapeutico
FI924088A7 (fi) Prostaglandiini F3a:n käyttö silmänpainetta laskevana aineena
FI813776L (fi) Amino-penicillin-derivat foerfarande foer dess framstaellning och terapeutiska kompositioner som innehaoller detta som aktivaemne
FI104232B1 (fi) Hirudiinijohdannaisten käyttö trombiini-inhibiittoreina
NO931914L (no) Anvendelse av halogenimider som brannhemmende midler
IT1219938B (it) Impiego farmaceutico del dietila-minoetil-destrano
IT8321398A1 (it) Preparazioni farmaceutiche per trattamento topico della cataratta
BR1100888A (pt) Variantes de ativador de plasminogênios de tecido, composições e métodos de uso da mesma
NO923642D0 (no) Anvendelse av 5-trans-prostaglandin f2alfa som et okulart hypotensivt middel
FI970807A0 (fi) Tiosemikarbatsidien käyttö lahonestoaineina